Search results
Results From The WOW.Com Content Network
UiPath's stock is trading at an estimated 30 times next year's profits, according to analyst expectations. However, I'm doubtful about whether the company will be profitable next year, given its ...
UiPath (NYSE: PATH) started out as a robotic automation company that helped customers build out tools whereby software robot agents could complete mundane tasks, such as data entry.
UiPath's stock only trades at 4 times next year's sales, but it could struggle to command a higher valuation unless it stays relevant in the rapidly shifting AI market. The better buy: Palantir
UiPath was founded in 2005 in Bucharest, Romania as DeskOver, by Romanian entrepreneurs Daniel Dines and Marius Tîrcă. [3] In 2013, the company released the first UiPath Desktop Automation product line, which gave companies RPA tools to automate manual and repetitive back office tasks. [3] In 2015, the company changed its name to UiPath. [3]
UiPath (NYSE: PATH) is at the crossroads of automation and artificial intelligence. Stock prices used were the afternoon prices of Dec. 18, 2024. The video was published on Dec. 20, 2024.
Home & Garden. Medicare
UiPath's P/S ratio dropped after its stock price plummeted on the news of its CEO change and reduction in fiscal 2025 revenue guidance. As a result, UiPath looks like a better value between these two.
As of the first quarter report, UiPath expects just $1.660 billion to $1.665 billion in ARR, likely a result of customers weighing the value of the company's services against competing AI products.